Redefining ‘success’: a systematic review and meta-analysis comparing outcomes between incomplete and complete revascularization

医学 荟萃分析 血运重建 内科学 外科 心肌梗塞
作者
Asim Rizvi,Seyed Mohammad Seyedsaadat,M. Hassan Murad,Waleed Brinjikji,Seán Fitzgerald,Ramanathan Kadirvel,Alejandro A. Rabinstein,David F. Kallmes
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:11 (1): 9-13 被引量:55
标识
DOI:10.1136/neurintsurg-2018-013950
摘要

Background Conventionally, ‘successful’ endovascular thrombectomy (EVT) had been defined as achieving revascularization of thrombolysis in cerebral infarction (TICI)−2B or greater, rather than as ‘complete’ (TICI-3) versus ‘incomplete’ (TICI-2B) revascularization. Purpose We performed a systematic review and meta-analysis of studies comparing clinical outcomes between patients with TICI-2B and TICI-3 revascularization. Methods Multiple databases were searched for relevant publications between January 2003 and March 2018. Studies comparing outcomes between the TICI-2B and the TICI-3 group of acute ischemic stroke (AIS) patients treated with EVT were included. Random effects meta-analysis was performed to evaluate outcomes among TICI-2B and TICI-3 groups. The following outcomes were assessed: good neurologic outcome (modified Rankin Scale (mRS)≤2 at day 90), mortality, and intracerebral hemorrhage (ICH). Results Twenty-one studies comprising 2747 patients were identified. Patients with TICI-2B revascularization had mRS≤2 at day 90 rates of 46% (391/847) compared with 66% (522/791) for TICI-3 patients (OR 0.46, 95% CI 0.37 to 0.57). Mortality rates were significantly higher in the TICI-2B group (78/570, 14%) than in the TICI-3 group (55/709, 8%) (OR 2.00, 95% CI 1.38 to 2.91). The ICH rates were also significantly higher in the TICI-2B group as compared with the TICI-3 group (31% [134/439] vs. 22% [108/490]; OR 2.20, 95% CI 1.47 to 3.30). Conclusions Differences in all major outcome measures were markedly better in patients with complete versus incomplete but still ‘successful’ revascularization using prior thresholds, with ORs in the order of those seen in recent definitive trials comparing EVT to an intravenous tissue plasminogen activator.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wszldmn发布了新的文献求助10
1秒前
WANDour发布了新的文献求助10
2秒前
等等等完成签到,获得积分10
3秒前
一毛钱买两颗糖完成签到,获得积分10
4秒前
清梦应助吴钰璐采纳,获得10
4秒前
bkagyin应助秀丽的巨人采纳,获得10
4秒前
沙漠水发布了新的文献求助10
5秒前
今后应助方半仙采纳,获得10
5秒前
炸梨酥完成签到,获得积分10
5秒前
茄子发布了新的文献求助30
7秒前
8秒前
8秒前
8秒前
清溪浅水XZ完成签到 ,获得积分10
10秒前
小程同学发布了新的文献求助10
10秒前
shunlibiye发布了新的文献求助20
10秒前
11秒前
潇湘飞云发布了新的文献求助10
12秒前
宝林发布了新的文献求助10
13秒前
13秒前
英俊的铭应助高高采纳,获得10
13秒前
14秒前
16秒前
吉吉国王发布了新的文献求助20
17秒前
MeiFanNao完成签到,获得积分10
18秒前
612发布了新的文献求助10
18秒前
halahj完成签到,获得积分10
18秒前
潇湘飞云完成签到,获得积分10
18秒前
吴小样发布了新的文献求助10
19秒前
123发布了新的文献求助10
20秒前
22秒前
搜集达人应助高会和采纳,获得10
23秒前
共享精神应助moyacheung采纳,获得30
23秒前
完美世界应助大大怪将军采纳,获得10
25秒前
无花果应助看文献了采纳,获得10
25秒前
雨村完成签到,获得积分10
26秒前
hangjias完成签到 ,获得积分10
26秒前
28秒前
充电宝应助科研通管家采纳,获得10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Applied Min-Max Approach to Missile Guidance and Control 5000
Metallurgy at high pressures and high temperatures 2000
Inorganic Chemistry Eighth Edition 1200
The Psychological Quest for Meaning 800
Signals, Systems, and Signal Processing 610
An Introduction to Medicinal Chemistry 第六版习题答案 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6329159
求助须知:如何正确求助?哪些是违规求助? 8145563
关于积分的说明 17085866
捐赠科研通 5383697
什么是DOI,文献DOI怎么找? 2855260
邀请新用户注册赠送积分活动 1832855
关于科研通互助平台的介绍 1684105